These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 32615723

  • 1. Gemigliptin Inhibits Interleukin-1β-Induced Endothelial-Mesenchymal Transition via Canonical-Bone Morphogenetic Protein Pathway.
    Hong OK, Lee SS, Yoo SJ, Lee MK, Kim MK, Baek KH, Song KH, Kwon HS.
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):384-395. PubMed ID: 32615723
    [Abstract] [Full Text] [Related]

  • 2. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms.
    Hwang HJ, Chung HS, Jung TW, Ryu JY, Hong HC, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH, Yoo HJ.
    Mol Cell Endocrinol; 2015 Apr 15; 405():25-34. PubMed ID: 25661535
    [Abstract] [Full Text] [Related]

  • 3. Adipose tissue-derived stromal cells' conditioned medium modulates endothelial-mesenchymal transition induced by IL-1β/TGF-β2 but does not restore endothelial function.
    Liguori TTA, Liguori GR, Moreira LFP, Harmsen MC.
    Cell Prolif; 2019 Nov 15; 52(6):e12629. PubMed ID: 31468648
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of gemigliptin against type II collagen degradation in human chondrocytes.
    Mohetaer M, Li G, Wang Y, Cao L.
    Biomed Pharmacother; 2018 Aug 15; 104():590-594. PubMed ID: 29803171
    [Abstract] [Full Text] [Related]

  • 5. The Phosphodiesterase-5 Inhibitor Vardenafil Improves the Activation of BMP Signaling in Response to Hydrogen Peroxide.
    Mao F, Han B, Jiang D, Zhang X, Pang T, Fan Y.
    Cardiovasc Drugs Ther; 2020 Feb 15; 34(1):41-52. PubMed ID: 32096002
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
    Song S, Liu L, Yu Y, Zhang R, Li Y, Cao W, Xiao Y, Fang G, Li Z, Wang X, Wang Q, Zhao X, Chen L, Wang Y, Wang Q.
    J Mol Cell Cardiol; 2019 Feb 15; 127():83-96. PubMed ID: 30529267
    [Abstract] [Full Text] [Related]

  • 7. Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice.
    Tsai TH, Lee CH, Cheng CI, Fang YN, Chung SY, Chen SM, Lin CJ, Wu CJ, Hang CL, Chen WY.
    Cells; 2019 Jun 14; 8(6):. PubMed ID: 31207939
    [Abstract] [Full Text] [Related]

  • 8. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
    Jiang Y, Zhou X, Hu R, Dai A.
    Int J Biochem Cell Biol; 2018 Dec 14; 105():52-60. PubMed ID: 30120989
    [Abstract] [Full Text] [Related]

  • 9. Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2.
    Sánchez-Duffhues G, García de Vinuesa A, van de Pol V, Geerts ME, de Vries MR, Janson SG, van Dam H, Lindeman JH, Goumans MJ, Ten Dijke P.
    J Pathol; 2019 Mar 14; 247(3):333-346. PubMed ID: 30430573
    [Abstract] [Full Text] [Related]

  • 10. Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes.
    Hwang HJ, Jung TW, Ryu JY, Hong HC, Choi HY, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH, Yoo HJ.
    Mol Cell Endocrinol; 2014 Jul 05; 392(1-2):1-7. PubMed ID: 24813659
    [Abstract] [Full Text] [Related]

  • 11. Effect of interleukin-1beta on osteogenic protein 1-induced signaling in adult human articular chondrocytes.
    Elshaier AM, Hakimiyan AA, Rappoport L, Rueger DC, Chubinskaya S.
    Arthritis Rheum; 2009 Jan 05; 60(1):143-54. PubMed ID: 19116903
    [Abstract] [Full Text] [Related]

  • 12. IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner.
    Maleszewska M, Moonen JR, Huijkman N, van de Sluis B, Krenning G, Harmsen MC.
    Immunobiology; 2013 Apr 05; 218(4):443-54. PubMed ID: 22739237
    [Abstract] [Full Text] [Related]

  • 13. Bone morphogenetic proteins.
    Chen D, Zhao M, Mundy GR.
    Growth Factors; 2004 Dec 05; 22(4):233-41. PubMed ID: 15621726
    [Abstract] [Full Text] [Related]

  • 14. Effect of interleukin-1β on bone morphogenetic protein-9-induced osteoblastic differentiation of human periodontal ligament fibroblasts.
    Ebe Y, Nakamura T, Hasegawa-Nakamura K, Noguchi K.
    Eur J Oral Sci; 2021 Aug 05; 129(4):e12792. PubMed ID: 33945653
    [Abstract] [Full Text] [Related]

  • 15. Bone morphogenetic protein 6-induced interleukin-1β expression in macrophages requires PU.1/Smad1 interaction.
    Lee GT, Jung YS, Lee JH, Kim WJ, Kim IY.
    Mol Immunol; 2011 Jul 05; 48(12-13):1540-7. PubMed ID: 21571370
    [Abstract] [Full Text] [Related]

  • 16. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
    Maleszewska M, Gjaltema RA, Krenning G, Harmsen MC.
    Cell Signal; 2015 Aug 05; 27(8):1589-96. PubMed ID: 25917318
    [Abstract] [Full Text] [Related]

  • 17. Endothelial Cells Tissue-Specific Origins Affects Their Responsiveness to TGF-β2 during Endothelial-to-Mesenchymal Transition.
    Ursoli Ferreira F, Eduardo Botelho Souza L, Hassibe Thomé C, Tomazini Pinto M, Origassa C, Salustiano S, Marcel Faça V, Olsen Câmara N, Kashima S, Tadeu Covas D.
    Int J Mol Sci; 2019 Jan 22; 20(3):. PubMed ID: 30678183
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of rapamycin on endothelial-to-mesenchymal transition in HUVECs through the Notch signaling pathway.
    Tian D, Zeng X, Wang W, Wang Z, Zhang Y, Wang Y.
    Vascul Pharmacol; 2019 Feb 22; 113():20-26. PubMed ID: 30336218
    [Abstract] [Full Text] [Related]

  • 19. The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    Tumour Biol; 2017 Oct 22; 39(10):1010428317722068. PubMed ID: 28982310
    [Abstract] [Full Text] [Related]

  • 20. KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway.
    Xu H, Huo R, Li H, Jiao Y, Weng J, Wang J, Yan Z, Zhang J, Zhao S, He Q, Sun Y, Wang S, Cao Y.
    Stroke Vasc Neurol; 2023 Jun 22; 8(3):197-206. PubMed ID: 36418055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.